Literature DB >> 11140334

Self-administration of two long-acting monoamine transport blockers in rhesus monkeys.

J A Lile1, D Morgan, C S Freedland, R S Sinnott, H M Davies, M A Nader.   

Abstract

RATIONALE: 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT) is a cocaine analog with high affinity at and selectivity for the dopamine transporter (DAT). 2beta-propanoyl-3beta-(2-naphthyl)-tropane (HD-23), like cocaine, binds with approximately equal affinity to the DAT, the serotonin transporter, and the norepinephrine transporter but has over a 100-fold higher affinity for these monoamine transporters than cocaine. The reinforcing effects of these drugs have not been evaluated in cocaine-na nonhuman primates.
OBJECTIVE: The primary goal of the present study was to examine the reinforcing effects of PTT and HD-23 in rhesus monkeys before and after a history of intravenous cocaine self-administration.
METHODS: Monkeys (n=4) were initially trained to respond under a fixed-ratio 30 schedule of food presentation. When responding was stable, saline, PTT (0.001-0.03 mg/kg per injection), and HD-23 (0.0003-0.0056 mg/kg per injection) were made available for self-administration for least five sessions per dose. Next, a cocaine dose-effect function (0.0003-0.3 mg/kg per injection) was determined and then

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11140334     DOI: 10.1007/s002130000554

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  Lower reinforcing strength of the phenyltropane cocaine analogs RTI-336 and RTI-177 compared to cocaine in nonhuman primates.

Authors:  Paul W Czoty; Jennifer L Martelle; F Ivy Carroll; Michael A Nader
Journal:  Pharmacol Biochem Behav       Date:  2010-05-24       Impact factor: 3.533

2.  A within-subject assessment of the discriminative stimulus and reinforcing effects of self-administered cocaine in rhesus monkeys.

Authors:  Jennifer L Martelle; Michael A Nader
Journal:  Psychopharmacology (Berl)       Date:  2008-09-21       Impact factor: 4.530

3.  Sex differences in the subjective effects of oral Δ9-THC in cannabis users.

Authors:  Jessica S Fogel; Thomas H Kelly; Philip M Westgate; Joshua A Lile
Journal:  Pharmacol Biochem Behav       Date:  2016-01-15       Impact factor: 3.533

4.  Effect of HD-23, a potent long acting cocaine-analog, on cocaine self-administration in rats.

Authors:  David C S Roberts; Kelly R Jungersmith; Rachel Phelan; Timothy M Gregg; Huw M L Davies
Journal:  Psychopharmacology (Berl)       Date:  2003-04-01       Impact factor: 4.530

5.  The reinforcing, self-reported performance and physiological effects of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in cannabis users.

Authors:  Joshua A Lile; Thomas H Kelly; Lon R Hays
Journal:  Behav Pharmacol       Date:  2010-02       Impact factor: 2.293

6.  Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices.

Authors:  Carrie E John; Sara R Jones
Journal:  Neuropharmacology       Date:  2007-03-16       Impact factor: 5.250

7.  Effects of the dopamine reuptake inhibitor PTT on reinstatement and on food- and cocaine-maintained responding in rhesus monkeys.

Authors:  Joshua A Lile; Drake Morgan; Anne M Birmingham; Huw M L Davies; Michael A Nader
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

Review 8.  Agents in development for the management of cocaine abuse.

Authors:  David A Gorelick; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors.

Authors:  Takato Hiranita; Paul L Soto; Amy H Newman; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2009-02-19       Impact factor: 4.030

10.  Development of a translational model to screen medications for cocaine use disorder II: Choice between intravenous cocaine and money in humans.

Authors:  Joshua A Lile; William W Stoops; Craig R Rush; S Stevens Negus; Paul E A Glaser; Kevin W Hatton; Lon R Hays
Journal:  Drug Alcohol Depend       Date:  2016-05-28       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.